China Universal Asset Management Co., Ltd. Dyne Therapeutics, Inc. Put Options Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DYN
# of Institutions
177Shares Held
87.1MCall Options Held
130KPut Options Held
209K-
Atlas Venture Life Science Advisors, LLC8.02MShares$333 Million28.49% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$326 Million31.49% of portfolio
-
Black Rock Inc. New York, NY5.39MShares$224 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.56MShares$189 Million4.27% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.25MShares$177 Million0.02% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $2.15B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...